StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3028% below fair value
$46.56+0.18 (+0.39%)

Close on Nov 20, 2026Market cap $1.39BP/E 19.2Yield 1.29%

Conmed gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Conmed's gross profit for the twelve months ending Sep 30, 2026 was $788.34M, up 7.9% year over year. For fiscal 2025 it was $750.48M, up 2.4% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is $750.48M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$750.48M+2.4%
FY2024Dec 31, 2024$733.03M+8.4%
FY2023Dec 31, 2023$676.25M+18.4%
FY2022Dec 31, 2022$571.25M+0.6%
FY2021Dec 31, 2021$568.04M+23.4%
FY2020Dec 31, 2020$460.30M-12.3%
FY2019Dec 31, 2019$524.72M+11.9%
FY2018Dec 31, 2018$469.11M+8.8%
FY2017Dec 31, 2017$431.04M+5.6%
FY2016Dec 31, 2016$408.33M+7.0%
FY2015Dec 31, 2015$381.70M-5.5%
FY2014Dec 31, 2014$404.06M-2.0%
FY2013Dec 31, 2013$412.42M+1.6%
FY2012Dec 31, 2012$405.84M+8.2%
FY2011Dec 31, 2011$374.93M+2.6%
FY2010Dec 31, 2010$365.38M+8.3%
FY2009Dec 31, 2009$337.33M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$189.15M+13.9%
Q2 FY2026Jun 30, 2026$197.46M+4.9%
Q1 FY2026Mar 31, 2026$183.45M+3.2%
Q4 FY2025Dec 31, 2025$218.29M+10.1%
Q3 FY2025Sep 30, 2025$166.12M-7.2%
Q2 FY2025Jun 30, 2025$188.32M+2.5%
Q1 FY2025Mar 31, 2025$177.75M+3.4%
Q4 FY2024Dec 31, 2024$198.34M+8.9%
Q3 FY2024Sep 30, 2024$179.00M+6.5%
Q2 FY2024Jun 30, 2024$183.73M+7.6%
Q1 FY2024Mar 31, 2024$171.97M+10.7%
Q4 FY2023Dec 31, 2023$182.18M+38.2%
Q3 FY2023Sep 30, 2023$168.06M+10.8%
Q2 FY2023Jun 30, 2023$170.69M+12.5%
Q1 FY2023Mar 31, 2023$155.32M+14.2%
Q4 FY2022Dec 31, 2022$131.86M-15.4%
Q3 FY2022Sep 30, 2022$151.62M+6.5%
Q2 FY2022Jun 30, 2022$151.78M+7.3%
Q1 FY2022Mar 31, 2022$135.99M+5.9%
Q4 FY2021Dec 31, 2021$155.86M+15.0%
Q3 FY2021Sep 30, 2021$142.31M+6.4%
Q2 FY2021Jun 30, 2021$141.42M+96.6%
Q1 FY2021Mar 31, 2021$128.45M+7.8%
Q4 FY2020Dec 31, 2020$135.51M-4.6%
Q3 FY2020Sep 30, 2020$133.70M+2.8%
Q2 FY2020Jun 30, 2020$71.93M-45.2%
Q1 FY2020Mar 31, 2020$119.16M-1.9%
Q4 FY2019Dec 31, 2019$141.98M+7.0%
Q3 FY2019Sep 30, 2019$130.11M+17.6%
Q2 FY2019Jun 30, 2019$131.19M+12.8%
Q1 FY2019Mar 31, 2019$121.44M+10.8%
Q4 FY2018Dec 31, 2018$132.66M+7.0%
Q3 FY2018Sep 30, 2018$110.63M+7.9%
Q2 FY2018Jun 30, 2018$116.27M+11.1%
Q1 FY2018Mar 31, 2018$109.56M+9.7%
Q4 FY2017Dec 31, 2017$123.96M+15.9%
Q3 FY2017Sep 30, 2017$102.55M–
Q2 FY2017Jun 30, 2017$104.65M–
Q1 FY2017Mar 31, 2017$99.89M–
Q4 FY2016Dec 31, 2016$106.96M–

More Conmed figures

See a number that looks wrong?